Biotech | November 20, 2021
Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Nelarabine is in a class of medications called antimetabolites
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
